MKI67 and neoplasm: IMR-32 tumours in PSCT exhibited a Ki67-index of 63±8.3%, similar to previous findings [20], and this proliferative index was not significantly altered by either of the administered doses of doxo, when compared to control (Table 3, Fig 3).